These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11599326)

  • 1. Raloxifene and breast cancer.
    Lorraine J
    CMAJ; 2001 Oct; 165(7):888. PubMed ID: 11599326
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemoprevention of breast cancer. Impact of a new therapeutic strategy].
    Kattan J; Ghosn M
    J Med Liban; 1999; 47(5):284-5. PubMed ID: 10887527
    [No Abstract]   [Full Text] [Related]  

  • 3. Reducing the risk of breast cancer.
    Chlebowski RT
    N Engl J Med; 2000 Jul; 343(3):191-8. PubMed ID: 10900280
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemoprevention of breast cancer: recommendations and rationale.
    Am Fam Physician; 2003 Mar; 67(6):1309-14. PubMed ID: 12674459
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing "unpreventable" cancers.
    Harv Womens Health Watch; 1999 Nov; 7(3):1. PubMed ID: 10521915
    [No Abstract]   [Full Text] [Related]  

  • 6. Until there's more information, caution advised in using tamoxifen or raloxifene for breast cancer prevention.
    Mayo Clin Health Lett; 1998 Jul; 16(7):4. PubMed ID: 9663019
    [No Abstract]   [Full Text] [Related]  

  • 7. [Chemopreventive effect of tamoxifen on familial breast cancer].
    Funahashi H
    Nihon Rinsho; 2000 Jun; 58(6):1267-71. PubMed ID: 10879052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Designer estrogens: breast cancer benefit, remaining questions.
    Health News; 1999 Jul; 5(9):6. PubMed ID: 10480007
    [No Abstract]   [Full Text] [Related]  

  • 9. Raloxifene and its role in breast cancer prevention.
    Eng-Wong J; Zujewski JA
    Expert Rev Anticancer Ther; 2004 Aug; 4(4):523-32. PubMed ID: 15270657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen, raloxifene and the prevention of breast cancer.
    Bentrem DJ; Craig Jordan V
    Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The STAR trial: evidence for raloxifene as a breast cancer risk reduction agent for postmenopausal women.
    Bevers TB
    J Natl Compr Canc Netw; 2007 Sep; 5(8):719-24. PubMed ID: 17927929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clear thinking on tamoxifen.
    Johns Hopkins Med Lett Health After 50; 1998 Jul; 10(5):1-2. PubMed ID: 9650523
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antiestrogens: mechanism of action and clinical applications].
    Barrón-González A; Arias-Martínez J; Castro-Romero I
    Salud Publica Mex; 2001; 43(6):577-84. PubMed ID: 11816234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 16. Tamoxifen, raloxifene, and the prevention of breast cancer.
    Jordan VC; Morrow M
    Endocr Rev; 1999 Jun; 20(3):253-78. PubMed ID: 10368771
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug insight: breast cancer prevention and tissue-targeted hormone replacement therapy.
    Labrie F
    Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):584-93. PubMed ID: 17643129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risks, benefits, and effects on quality of life of selective estrogen-receptor modulator therapy in postmenopausal women at increased risk of breast cancer.
    Ganz PA; Land SR
    Menopause; 2008; 15(4 Suppl):797-803. PubMed ID: 18596601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimising endocrine approaches for the chemoprevention of breast cancer beyond the Study of Tamoxifen and Raloxifene (STAR) trial.
    Jordan VC
    Eur J Cancer; 2006 Nov; 42(17):2909-13. PubMed ID: 17064889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiestrogenic effect of 20S-protopanaxadiol and its synergy with tamoxifen on breast cancer cells.
    Yu Y; Zhou Q; Hang Y; Bu X; Jia W
    Cancer; 2007 Jun; 109(11):2374-82. PubMed ID: 17464948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.